These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18599521)

  • 1. Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.
    Kawahara S; Hata Y; Kita T; Arita R; Miura M; Nakao S; Mochizuki Y; Enaida H; Kagimoto T; Goto Y; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2008 Oct; 57(10):2784-93. PubMed ID: 18599521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes.
    Hirayama K; Hata Y; Noda Y; Miura M; Yamanaka I; Shimokawa H; Ishibashi T
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3896-903. PubMed ID: 15505034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells.
    Miura M; Hata Y; Hirayama K; Kita T; Noda Y; Fujisawa K; Shimokawa H; Ishibashi T
    Exp Eye Res; 2006 May; 82(5):849-59. PubMed ID: 16310190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.
    Kita T; Hata Y; Arita R; Kawahara S; Miura M; Nakao S; Mochizuki Y; Enaida H; Goto Y; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17504-9. PubMed ID: 18952846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
    Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanisms of preretinal membrane contraction in proliferative vitreoretinal diseases and ROCK as a therapeutic target].
    Kita T
    Nippon Ganka Gakkai Zasshi; 2010 Nov; 114(11):927-34. PubMed ID: 21141072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by female sex hormones of collagen gel contraction mediated by retinal pigment epithelial cells.
    Kimura K; Orita T; Fujitsu Y; Liu Y; Wakuta M; Morishige N; Suzuki K; Sonoda KH
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2621-30. PubMed ID: 24609629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive strategy for the treatment of diabetic vitreoretinopathy].
    Hata Y
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):379-401; discussion 402. PubMed ID: 19348184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
    Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
    FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tranilast on experimental proliferative vitreoretinopathy.
    Ito S; Sakamoto T; Tahara Y; Goto Y; Akazawa K; Ishibashi T; Inomata H
    Graefes Arch Clin Exp Ophthalmol; 1999 Aug; 237(8):691-6. PubMed ID: 10459620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in proliferative vitreoretinopathy.
    El Ghrably I; Powe DG; Orr G; Fischer D; McIntosh R; Dua HS; Tighe PJ
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1473-9. PubMed ID: 15111604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor.
    Kita T; Hata Y; Kano K; Miura M; Nakao S; Noda Y; Shimokawa H; Ishibashi T
    Diabetes; 2007 Jan; 56(1):231-8. PubMed ID: 17192487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
    Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta2 in the vitreous in proliferative diabetic retinopathy.
    Hirase K; Ikeda T; Sotozono C; Nishida K; Sawa H; Kinoshita S
    Arch Ophthalmol; 1998 Jun; 116(6):738-41. PubMed ID: 9639441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases.
    Kojima S; Yamada T; Tamai M
    Jpn J Ophthalmol; 2001; 45(1):40-5. PubMed ID: 11163044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.